REFERENCES
- Sandmark S, Carlsson R, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study. Scand J Gastroenterol 1988, 23, 625–632
- Tytgat GNJ, Nio CY. The medical therapy of reflux oesophagitis. Clin Gastroenterol 1987, 1, 791–807
- Sontag S, Robinson M, McCallum RW, Barwick KW, Nardi R. Ranitidine therapy for gastroesophageal reflux disease: results of a large double-blind trial. Arch Intern Med 1987, 147, 1485–1494
- Furman D, Mensh R, Winan G, et al. A double-blind trial comparing high dose liquid antacid to placebo and cimetidine in improving symptoms and objective parameters of gastroesophageal reflux. Gastroenterology 1982, 82, 1062
- Graham DY, Patterson DJ. Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis. Dig Dis Sci 1983, 28, 559–563
- Grove O, Bekker C, Jeppe Hansen MG, et al. Ranitidine and high-dose antacid in reflux oesophagitis. Scand J Gastroenterol 1985, 20, 457–461
- Meyer C, Berenzeiweig H, Kuljiian B, Callachan C, McCallum RW. Controlled trial of antacid (AA) versus placebo (P) on relief of heartburn. Gastroenterology 1979, 76, 1201
- Berstad A, Weberg R, Frøyshov Larsen I, Hoel B, Hauer Jensen M. Relationship of hiatus hernia to reflux oesophagitis. A prospective study of coincidence, using endoscopy. Scand J Gastroenterol 1986, 21, 55–58
- Petrokubi RJ, Jeffries GH. Cimetidine versus antacid in scleroderma with reflux esophagitis. A randomized double-blind controlled study. Gastroenterology 1979, 77, 691–695
- Tytgat GN. Assessment of efficacy of cimetidine and other drugs in oesophageal reflux disease. In: Baron JH, eds. Cimetidine in the 80s. Churchill Livingstone, Edinburgh, 1981, 153–166
- Weberg R, Berstad A. Symptomatic effect of a low-dose antacid regimen in reflux oesophagitis. Scand J Gastroenterol 1989, 24, 401–406
- Higgs RH, Smyth RD, Castell DO. Gastric alkalinization. Effect on lower-esophageal-sphincter pressure and serum gastrin. N Engl J Med 1974, 291, 486–490
- Castell DO, Levine SM. Lower esophageal sphincter response to gastric alkalinization. A new mechanism for treatment of heartburn with antacids. Ann Intern Med 1971, 74, 223–227
- Johnsson F, Joelsson B, Florén CH, Nilsson Å. Bile salts in the esophagus of patients with esophagitis. Scand J Gastroenterol 1988, 23, 712–716
- Hollander D, Tarnawski A. Are antacids cytoprotective. Gut 1989, 30, 145–147
- Preclik G, Stange EF, Gerber K, Fetzer G, Horn H, Ditschuneit H. Stimulation of mucosal prostaglandin synthesis in human stomach and duodenum by antacid treatment. Gut 1989, 30, 148–151
- Weberg R, Aubert E, Dahlberg O, et al. Lowdose antacids or cimetidine for duodenal ulcer? Gastroenterology 1988, 95, 1465–1469
- Bardhan KD, Hunter JO, Miller JP, et al. Antacid maintenance therapy in the prevention of duodenal ulcer relapse. Gut 1988, 29, 1748–1745
- Farup PG, Andersen OK, Hasvold A, Petersen H, Bernklev T. Patient compliance to intensive antacid treatment. A multicentre study. Hepatogastroenterol 1986, 33, 260–261
- Berstad A, Weberg R. Antacids in the treatment of gastroduodenal ulcer. Scand J Gastroenterol 1986, 21, 385–391